Tachycardia, Ventricular Clinical Trial
Official title:
Physical Activity and Ventricular Arrhythmias
The purpose of the study is to determine the effect of aerobic interval training in patients with an implantable cardioverter defibrillator (ICD) on physical fitness, quality of life and the amount of serious ventricular arrhythmic events on short and long term.
In this study, participants will be randomly assigned to either take part in the exercise program or serve as control and live as usual. At baseline study visit, study researchers will review medical records to collect various information, including the reason for needing an ICD, the type and settings of the ICD, medication use and medical history etc. All participants will undergo blood collection, complete a questionnaire to assess quality of life and undergo examination with echocardiography and ECG. The ICD will be programmed accordingly to international guidelines regarding ICD-therapy and optimal monitoring, before each participant complete an exercise treadmill test to determine VO2 peak. They will wear a Holter monitor to record heart activity 48 hours before the test and 24 hours after the test. All participants will then be observed for 2 months before being randomly assigned to either intervention or control. During this observation period, they will wear a fitness activity tracker wristband to evaluate degree of physical activity and a Holter monitor to register number of premature ventricular contractions. Participants taking part in the interval training group will perform aerobic interval training 4 x 4 minutes intervals, 3 times a week for 12 weeks (week 1-12), whereas participants taking part in the control group will carry on with usual daily life with no lifestyle recommendations. All participants will then undergo a new period of observation (week 13-20) and repeat the tests and examinations performed at baseline and during the observation period prior to intervention/control. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01546207 -
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
|
N/A | |
Completed |
NCT04075253 -
Acute Effect of One Single Bout of High Intensity Exercise on the Tendency for Ventricular Arrhythmia
|
N/A | |
Completed |
NCT00000531 -
Antiarrhythmics Versus Implantable Defibrillators (AVID)
|
Phase 3 | |
Completed |
NCT00000480 -
Multicenter Unsustained Tachycardia Trial (MUSTT)
|
Phase 3 | |
Completed |
NCT05086510 -
Ablation Targets of Scar-related Ventricular Tachycardia Identified by Dynamic Functional Substrate Mapping
|
N/A | |
Completed |
NCT01940081 -
The Leiden Nonischemic Cardiomyopathy Study
|
||
Recruiting |
NCT01222156 -
Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping
|
Phase 1/Phase 2 | |
Terminated |
NCT00749671 -
Bispectral Index Monitoring During Testing in the Electrophysiology Lab
|
N/A | |
Recruiting |
NCT00385749 -
Right Ventricular Defibrillation Lead Select Site Study
|
N/A | |
Completed |
NCT00382928 -
Automatic External Defibrillation Monitoring in Cardiac Arrest
|
Phase 1 | |
Completed |
NCT00279279 -
PREPARE - Primary Prevention Parameters Evaluation
|
N/A | |
Terminated |
NCT00776087 -
European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)
|
N/A | |
Withdrawn |
NCT00510731 -
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
|
N/A | |
Completed |
NCT01572246 -
Effects of Monopolar Electrocautery Use During Surgery on Implanted Cardiac Defibrillators
|
N/A | |
Completed |
NCT00170287 -
SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)
|
Phase 4 | |
Completed |
NCT00147277 -
ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy
|
Phase 4 | |
Completed |
NCT00004559 -
Fatty Acid Antiarrhythmia Trial (FAAT)
|
Phase 3 | |
Completed |
NCT00702117 -
Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
|
Phase 4 | |
Completed |
NCT00232297 -
Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS
|
Phase 2 | |
Active, not recruiting |
NCT01639365 -
SmartTouch Catheter in Ablation of Ventricular Tachycardia
|
N/A |